Cargando…
Induction of ischemic tolerance as a promising treatment against diabetic retinopathy
Diabetic retinopathy is a leading cause of acquired blindness, and it is the most common ischemic disorder of the retina. Available treatments are not very effective. Efforts to inhibit diabetic retinopathy have focused either on highly specific therapeutic approaches for pharmacologic targets or us...
Autores principales: | Rosenstein, Ruth E., Fernandez, Diego C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211198/ https://www.ncbi.nlm.nih.gov/pubmed/25368643 http://dx.doi.org/10.4103/1673-5374.141782 |
Ejemplares similares
-
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
por: Klotzsche-von Ameln, Anne, et al.
Publicado: (2022) -
Oral tolerance induction protocols for treatment: an overview
por: Burks, Wesley
Publicado: (2011) -
Acute ischemic stroke biomarkers: a new era with diagnostic promise?
por: Bsat, Shadi, et al.
Publicado: (2021) -
Ischemic Tolerance Protects the Rat Retina from Glaucomatous Damage
por: Belforte, Nicolás, et al.
Publicado: (2011) -
Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)